A lot of money is being spent by governments, providers and payers to wire up all of health care in the belief that quality will improve and costs, health and administrative, will be lower. Are these outcomes being realized? It may simply be too soon to tell but a study published in the Journal of the American Medical Informatics Association attempts to find an answer from the plethora of recent studies on the subject. (JAMIA Article) The authors examined 42 papers, 33 deemed high quality, which contained an economic evaluation on some form of health information technology. Overall they judged that 23 papers had positive findings on the information system being studied providing a financial return and two were negative, while eight were inconclusive. As the authors note, there is such a wide range of systems studied, in such varied settings and with different evaluation methods, that coming up with a rational analysis is difficult. Our assessment of this paper and the studies cited is that while many appear to be positive, there are numerous limitations and flaws, and no clear conclusions can be drawn. Providers, in particular, seem to be quite dubious about whether the costs they are incurring are providing a benefit and high systems costs seems to be a factor in driving physicians to affiliate with hospitals, or even payers. We remain highly, highly skeptical that HIT will provide either an administrative or a health cost savings in the short, medium or long term. Quality improvements seem more likely, and that should be the primary goal of our system.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
May 8, 2024
Specialty Drug Pricing
One substantial cause of high and growing health care spending is the cost of specialty…
Commentary
May 7, 2024
Venture Capital in 2023
The venture capital community is still struggling with exits and poor investments.
Commentary
May 6, 2024
Drug Spending and Pricing
US drug spending remains high, with more expensive drugs continuing to come on the market…